Streetbeat News

Stock Prices

AAPL

AMD

NVDA

QCOM

TSM

VTI

VUG

Nvidia Corp (NASDAQ:NVDA) is trading higher on Thursday due to strong demand for its AI-related products. Nvidia, Apple, Qualcomm, and AMD have nearly fully booked TSMC's 3nm chip production until 2026. TSMC plans to increase 3nm production capacity. The U.S. government may add Russia to its semiconductor embargo list. Nvidia's stock has gained over 205% in the last 12 months. Investors can gain exposure to Nvidia through Vanguard Total Stock Market ETF (NYSE:VTI) and Vanguard Growth ETF (NYSE:VUG).

Portfolio Pulse from Anusuya Lahiri

June 13, 2024 | 1:31 pm

NEP

NextEra Energy Partners shares are trading lower after Mizuho downgraded the stock from Buy to Neutral.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2024 | 1:30 pm

AIQ

AVEM

BABA

META

Alibaba's affiliate Ant Group has invested $2.9 billion in AI research in 2023, focusing on its large language model BaiLing. The company has expanded its overseas operations and collaborated with over 30 e-wallet platforms for cross-border payments. Alibaba's stock has declined 11% over the past year.

Portfolio Pulse from Anusuya Lahiri

June 13, 2024 | 1:28 pm

PPIH

Perma-Pipe International Holdings (NASDAQ:PPIH) reported a significant improvement in its Q1 earnings, with EPS rising to $0.18 from a loss of $(0.14) YoY. Sales also increased by 15.73% to $34.32 million.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2024 | 1:28 pm

BBAR

BMA

DESP

GGAL

MELI

PAM

SUPV

YPF

Shares of US-listed Argentina stocks are trading higher after Argentina's Senate passed the Bases law.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2024 | 1:24 pm

FDIS

NKE

PMMAF

VCR

Nike's attempt to trademark 'footware' for tech-related products was rejected by the General Court of the European Union, following a challenge from Puma. The court ruled that 'footware' could be confused with the generic term 'footwear' and mandated Nike to cover Puma's legal expenses. Nike has the option to appeal to the European Court of Justice.

Portfolio Pulse from Shivani Kumaresan

June 13, 2024 | 1:24 pm

REVB

Revelation Biosciences has completed enrollment and dosing in its first human Phase 1 study of Gemini. The top-line data will include safety, tolerability, and biomarkers, supporting future development across multiple indications.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2024 | 1:22 pm

SIG

Signet Jewelers shares are trading lower following mixed Q1 earnings, which included an 8.9% drop in same store sales.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2024 | 1:20 pm

GCTK

Glucotrack has completed a 60-day preclinical study of its implantable continuous glucose monitor, confirming its potential for simplified management of painful diabetic neuropathy.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2024 | 1:20 pm

AEZS

Aeterna Zentaris has completed its Phase 3 DETECT-Trial for Macimorelin, aimed at diagnosing childhood onset growth hormone deficiency. Top-line data and full study results are expected in Q3 2024.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2024 | 1:20 pm